Affordability and Exceptional Care
Managing cost while also improving a patient’s health and quality of life are guideposts for our enterprise pharmacy solutions. Lumicera, our specialty pharmacy established 10 years ago, deploys an actual acquisition cost-plus model rarely seen within the market. We believe Lumicera remains the only true cost-plus specialty pharmacy in the United States.
Cost-plus for Lumicera is defined as acquisition cost plus a set fee for patient management. Other pharmacies apply a percentage-based fee on the drug cost. This can disincentivize the use of lower-cost, clinically appropriate medication because pharmacy revenues increase with higher drug costs. This also leads to higher costs for clients and patients. Lumicera charges a flat fee based on the complexity of care and special handling of the medication.
Lumicera's cost-plus model, in combination with the pass-through approach of Navitus, reduces the amount that clients and patients pay to access important medications.
Exceptional Patient Care and Satisfaction
Lumicera demonstrates excellence in supporting patients on complex therapies. Under their care model, patients access:
- Streamlined onboarding processes to expedite the time to start treatment
- Prior authorization support to navigate insurance protocols
- Specialized pharmacists who are able to provide disease state expertise and education throughout their journeys
This personalized support contributes to therapy compliance rates greater than 90%2.
